NCT05678166

Validation of Soluble Programmed Death-1 in Predicting Progression of Nodular-bronchiectatic Form of Nontuberculous Mycobacterial Lung Disease: a Multi-Country Research

RecruitingOBSERVATIONAL

Trial Details

Start: 2023-01-31Est. Completion: 2026-12-01

Enrollment target: 500 participants

Locations

Contact

MAC Lung DiseaseTreatment Refractory MAC Lung Disease

This is a pivotal Phase 2/3, double-blind, placebo-controlled study of epetraborole + OBR (Optimized Background Regimen)…

Birmingham, United StatesCompleted Dec 18, 2024

Cystic FibrosisPseudohypoaldosteronismNontuberculous Mycobacterial InfectionChronic Granulomatous DiseasePrimary Ciliary Dyskinesia

Healthy volunteers and patients with diseases that involve problems clearing mucus from the lungs will be examined and t…

Bethesda, United States

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.